Pyxis Oncology logo

Pyxis Oncology Share Price Today

(NASDAQ: PYXS)

Pyxis Oncology share price is $1.17 & ₹101.75 as on 6 Mar 2025, 2.30 'hrs' IST

$1.17

0.03

(2.63%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Pyxis Oncology share price in Dollar and Rupees. Guide to invest in Pyxis Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pyxis Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Pyxis Oncology share price movements

  • Today's Low: $1.12
    Today's High: $1.19

    Day's Volatility :5.88%

  • 52 Weeks Low: $1.07
    52 Weeks High: $6.68

    52 Weeks Volatility :83.98%

Pyxis Oncology (PYXS) Returns

PeriodPyxis Oncology, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-31.18%
3.7%
0.0%
6 Months
-66.57%
-2.8%
0.0%
1 Year
-81.37%
2.5%
0.0%
3 Years
-73.53%
12.9%
-11.6%

Pyxis Oncology (PYXS) Key Statistics

in dollars & INR

Previous Close
$1.14
Open
$1.15
Today's High
$1.19
Today's Low
$1.12
Market Capitalization
$69.6M
Today's Volume
$308.3K
52 Week High
$6.68
52 Week Low
$1.07
Revenue TTM
$16.1M
EBITDA
$-61.2M
Earnings Per Share (EPS)
$-1.06
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-39.34%

How to invest in Pyxis Oncology Stock (PYXS) from India?

It is very easy for Indian residents to invest directly in Pyxis Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pyxis Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pyxis Oncology or PYXS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pyxis Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pyxis Oncology shares which would translate to 0.743 fractional shares of Pyxis Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pyxis Oncology, in just a few clicks!

Returns in Pyxis Oncology (PYXS) for Indian investors in Rupees

The Pyxis Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pyxis Oncology investment value today

Current value as on today

₹23,579

Returns

₹76,421

(-76.42%)

Returns from Pyxis Oncology Stock

₹81,369 (-81.37%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Pyxis Oncology (PYXS)

-56%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Pyxis Oncology Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pyxis Oncology

  • LAURION CAPITAL MANAGEMENT LP

    6.10%

  • BlackRock Inc

    5.62%

  • Millennium Management LLC

    5.01%

  • Vanguard Group Inc

    4.11%

  • Geode Capital Management, LLC

    1.82%

  • Palo Alto Investors, LLC

    1.74%

Analyst Recommendation on Pyxis Oncology

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Pyxis Oncology(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pyxis Oncology Stock (PYXS)

What analysts predicted

Upside of 654.98%

Target:

$8.83

Current:

$1.17

Insights on Pyxis Oncology Stock (Ticker Symbol: PYXS)

  • Price Movement

    In the last 6 months, PYXS stock has moved down by -66.6%
  • PYXS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 147.9%
  • PYXS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 125.1%
  • Price to Sales

    ForPYXS every $1 of sales, investors are willing to pay $3.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Pyxis Oncology Technicals Summary

Sell

Neutral

Buy

Pyxis Oncology is currently in a neutral trading position according to technical analysis indicators.

Pyxis Oncology (PYXS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pyxis Oncology, Inc. logo
-22.52%
-66.57%
-81.37%
-73.53%
-91.14%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pyxis Oncology, Inc. logo
NA
NA
NA
-1.09
-0.39
-0.21
NA
2.59
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pyxis Oncology, Inc. logo
Buy
$69.6M
-91.14%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Pyxis Oncology

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients who previously progressed on PD-(L)1 inhibitors, which is in Phase 2 clinical trial for the treatment of solid tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and melanoma in combination with chemotherapy, radiation therapy, and immunotherapy. It has in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates directed to certain licensed targets, including PYX-201 and PYX-203, and products containing the ADC product candidates; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Organization
Pyxis Oncology
Employees
54
CEO
Dr. Lara S. Sullivan M.D., MBA
Industry
Services

Management People of Pyxis Oncology

NameTitle
Dr. Lara S. Sullivan M.D., MBA
CEO, President & Director
Ms. Pamela Yanchik Connealy M.B.A.
CFO & COO
Dr. Ken Kobayashi FACP, M.D.
Chief Medical Officer
Mr. Jitendra Wadhane
Chief Accounting Officer, Senior VP of Finance & Corporate Controller
Dr. Balu N. Balasubramanian Ph.D.
Interim Chief Technology Officer
Dr. Jan Pinkas Ph.D.
Chief Scientific Officer
Dr. Charles T. Gombar Ph.D.
Senior Vice President of Portfolio & Program Management
Mr. Stephen T. Worsley MBA
Senior VP & Chief Business Officer

Important FAQs about investing in PYXS Stock from India :

What is Pyxis Oncology share price today?

Pyxis Oncology share price today stands at $1.17, Open: $1.15 ; Previous Close: $1.14 ; High: $1.19 ; Low: $1.12 ; 52 Week High: $6.68 ; 52 Week Low: $1.07.

The stock opens at $1.15, after a previous close of $1.14. The stock reached a daily high of $1.19 and a low of $1.12, with a 52-week high of $6.68 and a 52-week low of $1.07.

Can Indians buy Pyxis Oncology shares?

Yes, Indians can invest in the Pyxis Oncology (PYXS) from India.

With INDmoney, you can buy Pyxis Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pyxis Oncology at zero transaction cost.

How can I buy Pyxis Oncology shares from India?

It is very easy to buy Pyxis Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pyxis Oncology (PYXS) be purchased?

Yes, you can buy fractional shares of Pyxis Oncology with INDmoney app.

What are the documents required to start investing in Pyxis Oncology stocks?

To start investing in Pyxis Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pyxis Oncology Stock (PYXS)?

Today’s highest price of Pyxis Oncology (PYXS) is $1.19.

Today’s lowest price of Pyxis Oncology (PYXS) is $1.12.

What is today's market capitalisation of Pyxis Oncology?

Today's market capitalisation of Pyxis Oncology PYXS is 69.6M

What is the 52 Week High and Low Range of Pyxis Oncology Stock (PYXS)?

  • 52 Week High

    $6.68

  • 52 Week Low

    $1.07

What are the historical returns of Pyxis Oncology (PYXS)?

  • 1 Month Returns

    -22.52%

  • 3 Months Returns

    -66.57%

  • 1 Year Returns

    -81.37%

  • 5 Years Returns

    -91.14%

Who is the Chief Executive Officer (CEO) of Pyxis Oncology ?

Dr. Lara S. Sullivan M.D., MBA is the current Chief Executive Officer (CEO) of Pyxis Oncology.